These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28643854)

  • 41. Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.
    Pistell PJ; Zhu M; Ingram DK
    Neuroscience; 2008 Mar; 152(3):594-600. PubMed ID: 18304749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early Activation of Experience-Independent Dendritic Spine Turnover in a Mouse Model of Alzheimer's Disease.
    Heiss JK; Barrett J; Yu Z; Haas LT; Kostylev MA; Strittmatter SM
    Cereb Cortex; 2017 Jul; 27(7):3660-3674. PubMed ID: 27365298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.
    Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX
    Neuroscience; 2012 Jul; 215():160-73. PubMed ID: 22542680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer's disease mice.
    Woodhouse A; Fernandez-Martos CM; Atkinson RAK; Hanson KA; Collins JM; O'Mara AR; Terblanche N; Skinner MW; Vickers JC; King AE
    BMC Anesthesiol; 2018 Apr; 18(1):47. PubMed ID: 29699479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.
    Jiao SS; Bu XL; Liu YH; Zhu C; Wang QH; Shen LL; Liu CH; Wang YR; Yao XQ; Wang YJ
    Neurotox Res; 2016 Feb; 29(2):256-66. PubMed ID: 26707129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model.
    Park TS; Ryu YK; Park HY; Kim JY; Go J; Noh JR; Kim YH; Hwang JH; Choi DH; Oh WK; Lee CH; Kim KS
    Int J Mol Med; 2017 Jan; 39(1):21-30. PubMed ID: 28004107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic anti-murine Aβ immunization preserves odor guided behaviors in an Alzheimer's β-amyloidosis model.
    Wesson DW; Morales-Corraliza J; Mazzella MJ; Wilson DA; Mathews PM
    Behav Brain Res; 2013 Jan; 237():96-102. PubMed ID: 23000537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
    Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
    FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct amyloid precursor protein processing machineries of the olfactory system.
    Kim JY; Rasheed A; Yoo SJ; Kim SY; Cho B; Son G; Yu SW; Chang KA; Suh YH; Moon C
    Biochem Biophys Res Commun; 2018 Jan; 495(1):533-538. PubMed ID: 29097202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model.
    Qiao J; Wang J; Wang H; Zhang Y; Zhu S; Adilijiang A; Guo H; Zhang R; Guo W; Luo G; Qiu Y; Xu H; Kong J; Huang Q; Li XM
    Glia; 2016 Feb; 64(2):240-54. PubMed ID: 26446044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
    FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
    Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
    Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice.
    Qiu H; Zhong R; Liu H; Zhang F; Li S; Le W
    J Alzheimers Dis; 2016; 50(3):669-85. PubMed ID: 26757041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebellar amyloid-β plaques: disturbed cortical circuitry in AβPP/PS1 transgenic mice as a model of familial Alzheimer's disease.
    Lomoio S; López-González I; Aso E; Carmona M; Torrejón-Escribano B; Scherini E; Ferrer I
    J Alzheimers Dis; 2012; 31(2):285-300. PubMed ID: 22561329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.
    Huang H; Nie S; Cao M; Marshall C; Gao J; Xiao N; Hu G; Xiao M
    Age (Dordr); 2016 Aug; 38(4):303-322. PubMed ID: 27439903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease.
    Wang H; He J; Zhang R; Zhu S; Wang J; Kong L; Tan Q; Li XM
    Behav Brain Res; 2012 Jul; 233(1):237-43. PubMed ID: 22595040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice.
    Li C; Zug C; Qu H; Schluesener H; Zhang Z
    Behav Brain Res; 2015 Mar; 281():32-42. PubMed ID: 25510196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.